Heron Therapeutics Ownership 2024 | Who Owns Heron Therapeutics Now?
Institutional Ownership
11.36%
Insider Ownership
0.72%
Retail Ownership
87.93%
Institutional Holders
87.00
Heron Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 17.67% | 2.45% | 26,713,503 | - | - | 93,497,261 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.70% | 0.00% | 8,615,922 | 501,206 | 6.18% | 30,155,727 | Jun 30, 2024 |
| BLACKROCK INC. | 5.51% | 0.00% | 8,325,385 | 1,039,357 | 14.27% | 29,138,849 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.03% | 0.05% | 7,600,000 | 4,689,989 | 161.17% | 26,600,000 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 4.62% | 14.01% | 6,986,744 | - | - | 24,453,604 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 4.31% | 0.45% | 6,512,866 | -3,598,684 | -35.59% | 22,795,031 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 4.18% | 0.01% | 6,327,742 | -46,842 | -0.73% | 22,147,098 | Jun 30, 2024 |
| STATE STREET CORP | 3.49% | 0.00% | 5,280,866 | 2,839,996 | 116.35% | 18,483,031,000 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 2.77% | 5.33% | 4,187,860 | -223,707 | -5.07% | 14,657,510 | Jun 30, 2024 |
| PALISADE CAPITAL MANAGEMENT, LP | 2.68% | 0.39% | 4,049,128 | 316,887 | 8.49% | 14,171,949 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.56% | 0.01% | 3,863,375 | 1,168,329 | 43.35% | 13,521,813 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.06% | 0.00% | 3,112,335 | 316,216 | 11.31% | 10,895,805 | Jun 30, 2024 |
| JW ASSET MANAGEMENT, LLC | 1.52% | 3.31% | 2,292,418 | - | - | 8,023,463 | Jun 30, 2024 |
| ORCHARD CAPITAL MANAGEMENT, LLC | 1.48% | 2.37% | 2,243,426 | -28,457 | -1.25% | 7,851,991 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.32% | 0.01% | 1,993,800 | -412,686 | -17.15% | 6,978,300 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.22% | 0.66% | 1,850,000 | - | - | 6,475,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.16% | 0.01% | 1,761,051 | 1,266,697 | 256.23% | 6,163,683 | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.04% | 2.22% | 1,578,501 | -66,284 | -4.03% | 5,524,754 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 1.00% | 0.84% | 1,513,164 | -300,000 | -16.55% | 5,296,074 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.99% | 0.14% | 1,495,266 | -1,280,938 | -46.14% | 5,233,431 | Jun 30, 2024 |
Heron Therapeutics's largest institutional shareholder is RUBRIC CAPITAL MANAGEMENT LP, holding 17.67% of the company's total share outstanding, currently valued at $93.50M. The top 10 institutional shareholders own together 55.95% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 4.62% | 14.01% | 6,986,744 | - | - | 24,453,604 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 2.77% | 5.33% | 4,187,860 | -223,707 | -5.07% | 14,657,510 | Jun 30, 2024 |
| JW ASSET MANAGEMENT, LLC | 1.52% | 3.31% | 2,292,418 | - | - | 8,023,463 | Jun 30, 2024 |
| RICHMOND BROTHERS, INC. | 0.24% | 2.47% | 356,558 | 59,852 | 20.17% | 1,247,954 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 17.67% | 2.45% | 26,713,503 | - | - | 93,497,261 | Jun 30, 2024 |
| ORCHARD CAPITAL MANAGEMENT, LLC | 1.48% | 2.37% | 2,243,426 | -28,457 | -1.25% | 7,851,991 | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.04% | 2.22% | 1,578,501 | -66,284 | -4.03% | 5,524,754 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.20% | 0.96% | 300,000 | - | - | 1,050,000 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 1.00% | 0.84% | 1,513,164 | -300,000 | -16.55% | 5,296,074 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.22% | 0.66% | 1,850,000 | - | - | 6,475,000 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.46% | 0.46% | 695,993 | 695,993 | 100.00% | 2,435,976 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 4.31% | 0.45% | 6,512,866 | -3,598,684 | -35.59% | 22,795,031 | Jun 30, 2024 |
| PALISADE CAPITAL MANAGEMENT, LP | 2.68% | 0.39% | 4,049,128 | 316,887 | 8.49% | 14,171,949 | Jun 30, 2024 |
| NEXPOINT ASSET MANAGEMENT, L.P. | 0.31% | 0.22% | 475,750 | - | - | 1,665,125 | Jun 30, 2024 |
| APEIRON RIA LLC | 0.12% | 0.20% | 188,635 | 64,635 | 52.13% | 660,223 | Jun 30, 2024 |
| MOTIV8 INVESTMENTS LLC | 0.05% | 0.20% | 77,680 | -37 | -0.05% | 271,881 | Jun 30, 2024 |
| AJOVISTA, LLC | 0.01% | 0.20% | 19,718 | 19,718 | 100.00% | 69,013 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.18% | 0.16% | 274,076 | -434 | -0.16% | 959,266 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.99% | 0.14% | 1,495,266 | -1,280,938 | -46.14% | 5,233,431 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.16% | 0.11% | 239,239 | 239,239 | 100.00% | 837,336 | Jun 30, 2024 |
The largest Heron Therapeutics shareholder by % of total assets is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company owns 6.99M shares of Heron Therapeutics (HRTX), representing 14.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.03% | 0.05% | 7,600,000 | 4,689,989 | 161.17% | 26,600,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.49% | 0.00% | 5,280,866 | 2,839,996 | 116.35% | 18,483,031,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.16% | 0.01% | 1,761,051 | 1,266,697 | 256.23% | 6,163,683 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.56% | 0.01% | 3,863,375 | 1,168,329 | 43.35% | 13,521,813 | Jun 30, 2024 |
| BLACKROCK INC. | 5.51% | 0.00% | 8,325,385 | 1,039,357 | 14.27% | 29,138,849 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.73% | 0.01% | 1,106,436 | 1,025,872 | 1273.36% | 3,872,526 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.46% | 0.46% | 695,993 | 695,993 | 100.00% | 2,435,976 | Jun 30, 2024 |
| MORGAN STANLEY | 0.51% | 0.00% | 767,861 | 568,862 | 285.86% | 2,687,519 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.40% | 0.00% | 607,135 | 568,238 | 1460.88% | 2,124,973 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.70% | 0.00% | 8,615,922 | 501,206 | 6.18% | 30,155,727 | Jun 30, 2024 |
| PALISADE CAPITAL MANAGEMENT, LP | 2.68% | 0.39% | 4,049,128 | 316,887 | 8.49% | 14,171,949 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.06% | 0.00% | 3,112,335 | 316,216 | 11.31% | 10,895,805 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.24% | 0.00% | 363,700 | 286,160 | 369.05% | 1,272,950 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.17% | 0.00% | 257,560 | 257,560 | 100.00% | 901,460 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.16% | 0.11% | 239,239 | 239,239 | 100.00% | 837,336 | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | 0.13% | 0.02% | 202,157 | 202,157 | 100.00% | 707,550 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.29% | 0.00% | 434,299 | 199,257 | 84.78% | 1,520,046 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.13% | 0.00% | 198,186 | 198,186 | 100.00% | 694,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.37% | 0.01% | 562,228 | 186,802 | 49.76% | 1,967,798 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.12% | 0.11% | 178,521 | 178,521 | 100.00% | 624,824 | Jun 30, 2024 |
As of Jun 30 2024, Heron Therapeutics's largest institutional buyer is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company purchased 4.69M stocks of HRTX, valued at $26.60M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 4.31% | 0.45% | 6,512,866 | -3,598,684 | -35.59% | 22,795,031 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.95% | 0.00% | 1,434,627 | -1,732,659 | -54.70% | 5,021,194 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.99% | 0.14% | 1,495,266 | -1,280,938 | -46.14% | 5,233,431 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.32% | 0.01% | 1,993,800 | -412,686 | -17.15% | 6,978,300 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 1.00% | 0.84% | 1,513,164 | -300,000 | -16.55% | 5,296,074 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 56,751 | -281,775 | -83.24% | 199,000 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.16% | 0.00% | 238,899 | -254,365 | -51.57% | 836,147 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 2.77% | 5.33% | 4,187,860 | -223,707 | -5.07% | 14,657,510 | Jun 30, 2024 |
| ZWEIG-DIMENNA ASSOCIATES LLC | 0.09% | 0.05% | 128,592 | -191,538 | -59.83% | 450,072 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.02% | 54,205 | -154,582 | -74.04% | 189,718 | Jun 30, 2024 |
| SEARLE & CO. | 0.01% | 0.01% | 11,000 | -75,250 | -87.25% | 38,500 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | - | - | - | -72,097 | -100.00% | - | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.04% | 2.22% | 1,578,501 | -66,284 | -4.03% | 5,524,754 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.01% | 0.00% | 16,192 | -58,946 | -78.45% | 56,672 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -56,282 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.34% | 0.00% | 507,227 | -54,757 | -9.74% | 1,775,295 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -51,029 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 4.18% | 0.01% | 6,327,742 | -46,842 | -0.73% | 22,147,098 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -32,615 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.01% | 0.00% | 12,529 | -30,000 | -70.54% | 45,000 | Jun 30, 2024 |
As of Jun 30 2024, Heron Therapeutics's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -3.60M shares of HRTX, valued at $22.80M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.46% | 0.46% | 695,993 | 695,993 | 100.00% | 2,435,976 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.17% | 0.00% | 257,560 | 257,560 | 100.00% | 901,460 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.16% | 0.11% | 239,239 | 239,239 | 100.00% | 837,336 | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | 0.13% | 0.02% | 202,157 | 202,157 | 100.00% | 707,550 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.12% | 0.11% | 178,521 | 178,521 | 100.00% | 624,824 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.09% | 0.00% | 143,002 | 143,002 | 100.00% | 500,507 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.06% | 0.00% | 98,182 | 98,182 | 100.00% | 343,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 63,159 | 63,159 | 100.00% | 221,057 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 61,761 | 61,761 | 100.00% | 215,291 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.00% | 54,252 | 54,252 | 100.00% | 189,882,000 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.03% | 0.01% | 48,073 | 48,073 | 100.00% | 168,256 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.01% | 36,128 | 36,128 | 100.00% | 125,715 | Jun 30, 2024 |
| SYNOVUS FINANCIAL CORP | 0.02% | 0.00% | 31,847 | 31,847 | 100.00% | 111,465 | Jun 30, 2024 |
| HORAN SECURITIES, INC. | 0.02% | 0.04% | 29,310 | 29,310 | 100.00% | 102,585 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | 0.00% | 26,868 | 26,868 | 100.00% | 94,038 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 24,573 | 24,573 | 100.00% | 86,006 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.01% | 0.00% | 22,304 | 22,304 | 100.00% | 78,064 | Jun 30, 2024 |
| AJOVISTA, LLC | 0.01% | 0.20% | 19,718 | 19,718 | 100.00% | 69,013 | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | 0.01% | 0.00% | 15,642 | 15,642 | 100.00% | 54,747 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.01% | 0.01% | 13,484 | 13,484 | 100.00% | 47,194 | Jun 30, 2024 |
| VALEO FINANCIAL ADVISORS, LLC | 0.01% | 0.00% | 12,747 | 12,747 | 100.00% | 44,615 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.01% | 0.00% | 12,685 | 12,685 | 100.00% | 44,398,000 | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 12,220 | 12,220 | 100.00% | 42,770 | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 12,189 | 12,189 | 100.00% | 42,662 | Jun 30, 2024 |
| HB WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 35,000 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.01% | 0.02% | 7,800 | 7,800 | 100.00% | 27,300 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 4,200 | 4,200 | 100.00% | 14,700 | Jun 30, 2024 |
| CWM, LLC | 0.00% | 0.00% | 4,066 | 4,066 | 100.00% | 14,000 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 1,805 | 1,805 | 100.00% | 6,318 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 1,465 | 1,465 | 100.00% | 5,128 | Jun 30, 2024 |
| CULLEN/FROST BANKERS, INC. | 0.00% | 0.00% | 1,186 | 1,186 | 100.00% | 4,151 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,095 | 1,095 | 100.00% | 3,833 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 1,070 | 1,070 | 100.00% | 3,745 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | 0.00% | 555 | 555 | 100.00% | 1,926 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 327 | 327 | 100.00% | 1,145 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 253 | 253 | 100.00% | 886 | Jun 30, 2024 |
| GREAT LAKES RETIREMENT, INC. | 0.00% | - | 99 | 99 | 100.00% | 347 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 85 | 85 | 100.00% | 298 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | 16 | 16 | 100.00% | 56 | Jun 30, 2024 |
Heron Therapeutics's largest new institutional shareholder by number of shares is ESSEX INVESTMENT MANAGEMENT CO LLC, purchased 695.99K shares, valued at $2.44M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUINN OPPORTUNITY PARTNERS LLC | - | - | - | -72,097 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -56,282 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -51,029 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -32,615 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -16,000 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -15,081 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -11,727 | -100.00% | - | Jun 30, 2024 |
| EQIS CAPITAL MANAGEMENT, INC. | - | - | - | -10,979 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -5,600 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,964 | -100.00% | - | Jun 30, 2024 |
| FUTURE FINANCIAL WEALTH MANAGMENT LLC | - | - | - | -3,500 | -100.00% | - | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -75 | -100.00% | - | Jun 30, 2024 |
| GPS WEALTH STRATEGIES GROUP, LLC | - | - | - | -72 | -100.00% | - | Jun 30, 2024 |
Heron Therapeutics's largest sold out institutional shareholder by shares sold is QUINN OPPORTUNITY PARTNERS LLC, sold -72.10K shares, valued at -, as of undefined.
Heron Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HIGHLAND FUNDS II | 1.58% | 23,381 | - | - | Dec 31, 2023 |
| HARTFORD HLS SERIES FUND II INC | 1.57% | 385,915 | - | - | Dec 31, 2023 |
| Jacob Funds Inc. | 1.32% | 302,081 | -81,809 | -21.31% | Feb 29, 2024 |
| MERIDIAN FUND INC | 0.86% | 2,012,442 | - | - | Mar 28, 2024 |
| Vanguard Montgomery Funds | 0.71% | 169,064 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.70% | 553,866 | -17,644 | -3.09% | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.35% | 21,815 | 21,815 | - | Feb 29, 2024 |
| HEARTLAND GROUP INC | 0.35% | 200,000 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.35% | 2,992,985 | - | - | Jan 31, 2024 |
| Zacks Trust | 0.26% | 23,816 | 23,816 | - | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.24% | 85,070 | - | - | Mar 31, 2024 |
| HIGHLAND GLOBAL ALLOCATION FUND | 0.23% | 232,800 | - | - | Dec 31, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.16% | 30,817 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.15% | 78,614 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.12% | 1,037,131 | - | - | Jan 31, 2024 |
| Morgan Creek Global Equity Long/Short Institutional Fund | 0.11% | 2,100 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.11% | 90,598 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.10% | 36,363 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.09% | 40,585 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.08% | 187,322 | - | - | Jan 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.07% | 278,688 | - | - | Dec 29, 2023 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.06% | 3,037,983 | - | - | Mar 28, 2024 |
| Humankind Benefit Corp | 0.04% | 988 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.04% | 96,200 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.04% | 120,837 | - | - | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.03% | 49,550 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.03% | 379,615 | -308,486 | -44.83% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 185,313 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 15,592 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.03% | 175,793 | - | - | Aug 31, 2023 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.03% | 781,147 | - | - | Mar 31, 2024 |
| NEXPOINT DIVERSIFIED REAL ESTATE TRUST | 0.03% | 242,950 | - | - | Jun 30, 2022 |
| UNIFIED SERIES TRUST | 0.02% | 350,000 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 62,474 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,789,592 | - | - | Jan 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.02% | 36,700 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 6,387,552 | -1,211,313 | -15.94% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 149,372 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,785 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 64,598 | - | - | Mar 31, 2020 |
| ALPS ETF Trust | 0.01% | 135,134 | - | - | Feb 29, 2024 |
| ROYCE FUND | 0.01% | 70,000 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 173,782 | -2,011 | -1.14% | Mar 31, 2024 |
| North Square Investments Trust | 0.01% | 84,767 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 106,346 | 682 | 0.65% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 73,652 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 431,590 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.01% | 19,619 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.01% | 5,486 | 281 | 5.40% | Sep 30, 2023 |
| VANGUARD HORIZON FUNDS | 0.01% | 165,790 | -998,924 | -85.77% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 287,914 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,325,320 | 86,052 | 6.94% | Feb 29, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 13,969 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.01% | 238,455 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 20,955 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 42,807 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.01% | 208,973 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 246,845 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.00% | 107,267 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 647,709 | - | - | Jan 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 38,550 | - | - | Dec 31, 2023 |
| Weiss Strategic Interval Fund | 0.00% | 13,369 | 13,369 | - | Sep 30, 2022 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 18,479 | -209 | -1.12% | Mar 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 3,871,949 | - | - | Feb 29, 2024 |
| NEXPOINT FUNDS I | 0.00% | 12,000 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 7,993 | 5,095 | 175.81% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 15,611 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,128 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 78,015 | 4,124 | 5.58% | Mar 31, 2024 |
| VALIC Co II | 0.00% | 80,972 | 2,723 | 3.48% | Feb 28, 2021 |
| JPMORGAN INSURANCE TRUST | 0.00% | 27,500 | - | - | Mar 31, 2023 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 217,348 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 22,233 | -1,828 | -7.60% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 34,692 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 206,867 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,200 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 359,557 | 34,899 | 10.75% | Feb 29, 2024 |
| Virtus Investment Trust | 0.00% | 48,815 | - | - | Mar 28, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 226,798 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 723 | - | - | Apr 30, 2021 |
| SCHWAB STRATEGIC TRUST | 0.00% | 730,105 | 25,574 | 3.63% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 33,179 | -8,176 | -19.77% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,817 | - | - | Mar 31, 2024 |
| PACIFIC FUNDS SERIES TRUST | 0.00% | 238,522 | - | - | Mar 31, 2023 |
| Voya INVESTORS TRUST | 0.00% | 42,900 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 3,600 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 41,034 | - | - | Feb 29, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 927,043 | - | - | Mar 31, 2024 |
| Tidal ETF Trust | 0.00% | 8,133 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 38,217 | 6,400 | 20.12% | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 702,784 | - | - | Jan 31, 2024 |
| SSGA FUNDS | 0.00% | 245 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 3,312 | -631 | -16.00% | Jan 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 6,694 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 518,284 | 453,974 | 705.92% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 38,627 | - | - | Jan 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,977 | - | - | Dec 31, 2023 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 52,900 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 10,272 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,661 | - | - | Mar 28, 2024 |
Heron Therapeutics's largest mutual fund holder by % of total assets is "HIGHLAND FUNDS II", owning 23.38K shares, compromising 1.58% of its total assets.
Heron Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 87 | -47.27% |
| 31 Mar, 24 | 165 | 5.77% |
| 31 Dec, 23 | 156 | 11.43% |
| 30 Sep, 23 | 140 | -6.04% |
| 30 Jun, 23 | 149 | -8.02% |
| 31 Mar, 23 | 162 | -10.00% |
| 31 Dec, 22 | 180 | -2.17% |
| 30 Sep, 22 | 184 | 7.60% |
| 30 Jun, 22 | 171 | -13.20% |
| 31 Mar, 22 | 197 | -5.74% |
| 31 Dec, 21 | 209 | 1.95% |
| 30 Sep, 21 | 205 | 4.06% |
| 30 Jun, 21 | 197 | -3.90% |
| 31 Mar, 21 | 205 | 7.33% |
| 31 Dec, 20 | 191 | 5.52% |
| 30 Sep, 20 | 181 | -9.95% |
| 30 Jun, 20 | 201 | -3.83% |
| 31 Mar, 20 | 209 | 1.95% |
| 31 Dec, 19 | 205 | 7.33% |
| 30 Sep, 19 | 191 | 2.69% |
| 30 Jun, 19 | 186 | -11.00% |
| 31 Mar, 19 | 209 | 11.17% |
| 31 Dec, 18 | 188 | -10.05% |
| 30 Sep, 18 | 209 | -4.57% |
| 30 Jun, 18 | 219 | 28.07% |
| 31 Mar, 18 | 171 | 21.28% |
| 31 Dec, 17 | 141 | 21.55% |
| 30 Sep, 17 | 116 | -2.52% |
| 30 Jun, 17 | 119 | 9.17% |
| 31 Mar, 17 | 109 | - |
| 31 Dec, 16 | 109 | 3.81% |
| 30 Sep, 16 | 105 | - |
| 30 Jun, 16 | 105 | -7.08% |
| 31 Mar, 16 | 113 | -5.04% |
| 31 Dec, 15 | 119 | -0.83% |
| 30 Sep, 15 | 120 | 22.45% |
| 30 Jun, 15 | 98 | 36.11% |
| 31 Mar, 15 | 72 | 12.50% |
| 31 Dec, 14 | 64 | 12.28% |
| 30 Sep, 14 | 57 | -14.93% |
| 30 Jun, 14 | 67 | 67.50% |
| 31 Mar, 14 | 40 | - |
As of 30 Jun 24, 87 institutions are holding Heron Therapeutics's shares, representing a decrease of -47.27% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 17,169,497 | -85.61% |
| 31 Mar, 24 | 119,336,211 | 6.43% |
| 31 Dec, 23 | 112,127,927 | -4.94% |
| 30 Sep, 23 | 117,952,089 | 19.92% |
| 30 Jun, 23 | 98,354,908 | -8.65% |
| 31 Mar, 23 | 107,667,956 | -6.79% |
| 31 Dec, 22 | 115,513,614 | -5.24% |
| 30 Sep, 22 | 121,905,111 | 5.78% |
| 30 Jun, 22 | 115,247,066 | -2.65% |
| 31 Mar, 22 | 118,384,795 | 0.65% |
| 31 Dec, 21 | 117,623,696 | 8.55% |
| 30 Sep, 21 | 108,360,022 | 4.37% |
| 30 Jun, 21 | 103,821,665 | 13.95% |
| 31 Mar, 21 | 91,113,647 | 0.96% |
| 31 Dec, 20 | 90,247,537 | -0.63% |
| 30 Sep, 20 | 90,822,316 | 2.51% |
| 30 Jun, 20 | 88,595,358 | -4.51% |
| 31 Mar, 20 | 92,780,927 | -6.32% |
| 31 Dec, 19 | 99,035,446 | 8.33% |
| 30 Sep, 19 | 91,416,194 | -2.62% |
| 30 Jun, 19 | 93,875,489 | 1.10% |
| 31 Mar, 19 | 92,852,447 | 1.64% |
| 31 Dec, 18 | 91,350,178 | 4.40% |
| 30 Sep, 18 | 87,502,203 | 1.93% |
| 30 Jun, 18 | 85,844,780 | 5.52% |
| 31 Mar, 18 | 81,350,196 | 17.96% |
| 31 Dec, 17 | 68,966,717 | 8.77% |
| 30 Sep, 17 | 63,406,316 | -8.92% |
| 30 Jun, 17 | 69,617,417 | -2.85% |
| 31 Mar, 17 | 71,662,200 | 36.07% |
| 31 Dec, 16 | 52,666,790 | 2.73% |
| 30 Sep, 16 | 51,266,532 | 9.09% |
| 30 Jun, 16 | 46,994,887 | 4.39% |
| 31 Mar, 16 | 45,017,498 | -0.93% |
| 31 Dec, 15 | 45,438,763 | -5.12% |
| 30 Sep, 15 | 47,892,620 | 32.32% |
| 30 Jun, 15 | 36,193,401 | 36.86% |
| 31 Mar, 15 | 26,445,902 | 7.62% |
| 31 Dec, 14 | 24,573,892 | 0.86% |
| 30 Sep, 14 | 24,365,107 | -8.23% |
| 30 Jun, 14 | 26,551,608 | 27.64% |
| 31 Mar, 14 | 20,802,029 | - |
Heron Therapeutics (HRTX) has 17.17M shares outstanding as of 30 Jun 24, down -85.61% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.36% | 0.18% |
| 31 Mar, 24 | 79.41% | 1.33% |
| 31 Dec, 23 | 77.33% | 0.80% |
| 30 Sep, 23 | 98.52% | 1.45% |
| 30 Jun, 23 | 82.48% | 1.01% |
| 31 Mar, 23 | 90.29% | 0.92% |
| 31 Dec, 22 | 98.83% | 0.83% |
| 30 Sep, 22 | 109.10% | 0.86% |
| 30 Jun, 22 | 112.54% | 0.84% |
| 31 Mar, 22 | 115.92% | 0.81% |
| 31 Dec, 21 | 119.45% | 1.06% |
| 30 Sep, 21 | 106.33% | 0.96% |
| 30 Jun, 21 | 105.45% | 1.06% |
| 31 Mar, 21 | 99.70% | 1.02% |
| 31 Dec, 20 | 99.08% | 0.99% |
| 30 Sep, 20 | 99.97% | 1.05% |
| 30 Jun, 20 | 97.62% | 0.93% |
| 31 Mar, 20 | 102.62% | 0.70% |
| 31 Dec, 19 | 121.10% | 0.93% |
| 30 Sep, 19 | 114.36% | 0.82% |
| 30 Jun, 19 | 118.01% | 0.84% |
| 31 Mar, 19 | 118.41% | 0.76% |
| 31 Dec, 18 | 124.81% | 0.99% |
| 30 Sep, 18 | 112.45% | 0.79% |
| 30 Jun, 18 | 119.31% | 0.76% |
| 31 Mar, 18 | 125.69% | 1.11% |
| 31 Dec, 17 | 106.56% | 0.78% |
| 30 Sep, 17 | 117.04% | 0.70% |
| 30 Jun, 17 | 129.42% | 0.64% |
| 31 Mar, 17 | 141.82% | 0.79% |
| 31 Dec, 16 | 134.08% | 0.78% |
| 30 Sep, 16 | 131.07% | 0.81% |
| 30 Jun, 16 | 126.85% | 0.82% |
| 31 Mar, 16 | 124.26% | 0.66% |
| 31 Dec, 15 | 137.36% | 0.77% |
| 30 Sep, 15 | 133.88% | 0.98% |
| 30 Jun, 15 | 116.62% | 1.44% |
| 31 Mar, 15 | 89.98% | 1.05% |
| 31 Dec, 14 | 92.49% | 1.31% |
| 30 Sep, 14 | 84.01% | 0.70% |
| 30 Jun, 14 | 109.42% | 1.42% |
| 31 Mar, 14 | 87.82% | - |
As of 30 Jun 24, Heron Therapeutics is held by 11.36% institutional shareholders, representing a 0.18% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 43 | -39.44% |
| 31 Mar, 24 | 71 | -4.05% |
| 31 Dec, 23 | 74 | 42.31% |
| 30 Sep, 23 | 52 | -14.75% |
| 30 Jun, 23 | 61 | - |
| 31 Mar, 23 | 61 | -23.75% |
| 31 Dec, 22 | 80 | -11.11% |
| 30 Sep, 22 | 90 | 28.57% |
| 30 Jun, 22 | 70 | -27.84% |
| 31 Mar, 22 | 97 | -3.00% |
| 31 Dec, 21 | 100 | 3.09% |
| 30 Sep, 21 | 97 | -3.96% |
| 30 Jun, 21 | 101 | 3.06% |
| 31 Mar, 21 | 98 | 22.50% |
| 31 Dec, 20 | 80 | - |
| 30 Sep, 20 | 80 | -24.53% |
| 30 Jun, 20 | 106 | -10.92% |
| 31 Mar, 20 | 119 | -0.83% |
| 31 Dec, 19 | 120 | 25.00% |
| 30 Sep, 19 | 96 | -2.04% |
| 30 Jun, 19 | 98 | -14.04% |
| 31 Mar, 19 | 114 | 25.27% |
| 31 Dec, 18 | 91 | -14.15% |
| 30 Sep, 18 | 106 | -16.54% |
| 30 Jun, 18 | 127 | 19.81% |
| 31 Mar, 18 | 106 | 30.86% |
| 31 Dec, 17 | 81 | 55.77% |
| 30 Sep, 17 | 52 | -13.33% |
| 30 Jun, 17 | 60 | -21.05% |
| 31 Mar, 17 | 76 | 55.10% |
| 31 Dec, 16 | 49 | -5.77% |
| 30 Sep, 16 | 52 | -5.45% |
| 30 Jun, 16 | 55 | 10.00% |
| 31 Mar, 16 | 50 | -24.24% |
| 31 Dec, 15 | 66 | -13.16% |
| 30 Sep, 15 | 76 | 16.92% |
| 30 Jun, 15 | 65 | 51.16% |
| 31 Mar, 15 | 43 | 7.50% |
| 31 Dec, 14 | 40 | 25.00% |
| 30 Sep, 14 | 32 | -39.62% |
| 30 Jun, 14 | 53 | 32.50% |
| 31 Mar, 14 | 40 | - |
43 institutional shareholders have increased their position in HRTX stock as of 30 Jun 24 compared to 71 in the previous quarter (a -39.44% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -63.83% |
| 31 Mar, 24 | 47 | 27.03% |
| 31 Dec, 23 | 37 | -5.13% |
| 30 Sep, 23 | 39 | -15.22% |
| 30 Jun, 23 | 46 | -13.21% |
| 31 Mar, 23 | 53 | -10.17% |
| 31 Dec, 22 | 59 | 34.09% |
| 30 Sep, 22 | 44 | -21.43% |
| 30 Jun, 22 | 56 | 16.67% |
| 31 Mar, 22 | 48 | -15.79% |
| 31 Dec, 21 | 57 | 18.75% |
| 30 Sep, 21 | 48 | -2.04% |
| 30 Jun, 21 | 49 | -20.97% |
| 31 Mar, 21 | 62 | - |
| 31 Dec, 20 | 62 | -3.13% |
| 30 Sep, 20 | 64 | 18.52% |
| 30 Jun, 20 | 54 | 8.00% |
| 31 Mar, 20 | 50 | - |
| 31 Dec, 19 | 50 | 19.05% |
| 30 Sep, 19 | 42 | -19.23% |
| 30 Jun, 19 | 52 | 4.00% |
| 31 Mar, 19 | 50 | -15.25% |
| 31 Dec, 18 | 59 | -3.28% |
| 30 Sep, 18 | 61 | 7.02% |
| 30 Jun, 18 | 57 | 54.05% |
| 31 Mar, 18 | 37 | 37.04% |
| 31 Dec, 17 | 27 | - |
| 30 Sep, 17 | 27 | -3.57% |
| 30 Jun, 17 | 28 | 100.00% |
| 31 Mar, 17 | 14 | -58.82% |
| 31 Dec, 16 | 34 | 36.00% |
| 30 Sep, 16 | 25 | 8.70% |
| 30 Jun, 16 | 23 | -39.47% |
| 31 Mar, 16 | 38 | 35.71% |
| 31 Dec, 15 | 28 | 47.37% |
| 30 Sep, 15 | 19 | -5.00% |
| 30 Jun, 15 | 20 | 42.86% |
| 31 Mar, 15 | 14 | 55.56% |
| 31 Dec, 14 | 9 | -18.18% |
| 30 Sep, 14 | 11 | 10.00% |
| 30 Jun, 14 | 10 | - |
| 31 Mar, 14 | - | - |
17 institutional shareholders have reduced their position in HRTX stock as of 30 Jun 24 compared to 47 in the previous quarter (a -63.83% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 87 | -47.27% | 17,169,497 | -85.61% | 11.36% | 0.18% | 43 | -39.44% | 17 | -63.83% |
| 31 Mar, 24 | 165 | 5.77% | 119,336,211 | 6.43% | 79.41% | 1.33% | 71 | -4.05% | 47 | 27.03% |
| 31 Dec, 23 | 156 | 11.43% | 112,127,927 | -4.94% | 77.33% | 0.80% | 74 | 42.31% | 37 | -5.13% |
| 30 Sep, 23 | 140 | -6.04% | 117,952,089 | 19.92% | 98.52% | 1.45% | 52 | -14.75% | 39 | -15.22% |
| 30 Jun, 23 | 149 | -8.02% | 98,354,908 | -8.65% | 82.48% | 1.01% | 61 | - | 46 | -13.21% |
| 31 Mar, 23 | 162 | -10.00% | 107,667,956 | -6.79% | 90.29% | 0.92% | 61 | -23.75% | 53 | -10.17% |
| 31 Dec, 22 | 180 | -2.17% | 115,513,614 | -5.24% | 98.83% | 0.83% | 80 | -11.11% | 59 | 34.09% |
| 30 Sep, 22 | 184 | 7.60% | 121,905,111 | 5.78% | 109.10% | 0.86% | 90 | 28.57% | 44 | -21.43% |
| 30 Jun, 22 | 171 | -13.20% | 115,247,066 | -2.65% | 112.54% | 0.84% | 70 | -27.84% | 56 | 16.67% |
| 31 Mar, 22 | 197 | -5.74% | 118,384,795 | 0.65% | 115.92% | 0.81% | 97 | -3.00% | 48 | -15.79% |
| 31 Dec, 21 | 209 | 1.95% | 117,623,696 | 8.55% | 119.45% | 1.06% | 100 | 3.09% | 57 | 18.75% |
| 30 Sep, 21 | 205 | 4.06% | 108,360,022 | 4.37% | 106.33% | 0.96% | 97 | -3.96% | 48 | -2.04% |
| 30 Jun, 21 | 197 | -3.90% | 103,821,665 | 13.95% | 105.45% | 1.06% | 101 | 3.06% | 49 | -20.97% |
| 31 Mar, 21 | 205 | 7.33% | 91,113,647 | 0.96% | 99.70% | 1.02% | 98 | 22.50% | 62 | - |
| 31 Dec, 20 | 191 | 5.52% | 90,247,537 | -0.63% | 99.08% | 0.99% | 80 | - | 62 | -3.13% |
| 30 Sep, 20 | 181 | -9.95% | 90,822,316 | 2.51% | 99.97% | 1.05% | 80 | -24.53% | 64 | 18.52% |
| 30 Jun, 20 | 201 | -3.83% | 88,595,358 | -4.51% | 97.62% | 0.93% | 106 | -10.92% | 54 | 8.00% |
| 31 Mar, 20 | 209 | 1.95% | 92,780,927 | -6.32% | 102.62% | 0.70% | 119 | -0.83% | 50 | - |
| 31 Dec, 19 | 205 | 7.33% | 99,035,446 | 8.33% | 121.10% | 0.93% | 120 | 25.00% | 50 | 19.05% |
| 30 Sep, 19 | 191 | 2.69% | 91,416,194 | -2.62% | 114.36% | 0.82% | 96 | -2.04% | 42 | -19.23% |
| 30 Jun, 19 | 186 | -11.00% | 93,875,489 | 1.10% | 118.01% | 0.84% | 98 | -14.04% | 52 | 4.00% |
| 31 Mar, 19 | 209 | 11.17% | 92,852,447 | 1.64% | 118.41% | 0.76% | 114 | 25.27% | 50 | -15.25% |
| 31 Dec, 18 | 188 | -10.05% | 91,350,178 | 4.40% | 124.81% | 0.99% | 91 | -14.15% | 59 | -3.28% |
| 30 Sep, 18 | 209 | -4.57% | 87,502,203 | 1.93% | 112.45% | 0.79% | 106 | -16.54% | 61 | 7.02% |
| 30 Jun, 18 | 219 | 28.07% | 85,844,780 | 5.52% | 119.31% | 0.76% | 127 | 19.81% | 57 | 54.05% |
| 31 Mar, 18 | 171 | 21.28% | 81,350,196 | 17.96% | 125.69% | 1.11% | 106 | 30.86% | 37 | 37.04% |
| 31 Dec, 17 | 141 | 21.55% | 68,966,717 | 8.77% | 106.56% | 0.78% | 81 | 55.77% | 27 | - |
| 30 Sep, 17 | 116 | -2.52% | 63,406,316 | -8.92% | 117.04% | 0.70% | 52 | -13.33% | 27 | -3.57% |
| 30 Jun, 17 | 119 | 9.17% | 69,617,417 | -2.85% | 129.42% | 0.64% | 60 | -21.05% | 28 | 100.00% |
| 31 Mar, 17 | 109 | - | 71,662,200 | 36.07% | 141.82% | 0.79% | 76 | 55.10% | 14 | -58.82% |
| 31 Dec, 16 | 109 | 3.81% | 52,666,790 | 2.73% | 134.08% | 0.78% | 49 | -5.77% | 34 | 36.00% |
| 30 Sep, 16 | 105 | - | 51,266,532 | 9.09% | 131.07% | 0.81% | 52 | -5.45% | 25 | 8.70% |
| 30 Jun, 16 | 105 | -7.08% | 46,994,887 | 4.39% | 126.85% | 0.82% | 55 | 10.00% | 23 | -39.47% |
| 31 Mar, 16 | 113 | -5.04% | 45,017,498 | -0.93% | 124.26% | 0.66% | 50 | -24.24% | 38 | 35.71% |
| 31 Dec, 15 | 119 | -0.83% | 45,438,763 | -5.12% | 137.36% | 0.77% | 66 | -13.16% | 28 | 47.37% |
| 30 Sep, 15 | 120 | 22.45% | 47,892,620 | 32.32% | 133.88% | 0.98% | 76 | 16.92% | 19 | -5.00% |
| 30 Jun, 15 | 98 | 36.11% | 36,193,401 | 36.86% | 116.62% | 1.44% | 65 | 51.16% | 20 | 42.86% |
| 31 Mar, 15 | 72 | 12.50% | 26,445,902 | 7.62% | 89.98% | 1.05% | 43 | 7.50% | 14 | 55.56% |
| 31 Dec, 14 | 64 | 12.28% | 24,573,892 | 0.86% | 92.49% | 1.31% | 40 | 25.00% | 9 | -18.18% |
| 30 Sep, 14 | 57 | -14.93% | 24,365,107 | -8.23% | 84.01% | 0.70% | 32 | -39.62% | 11 | 10.00% |
| 30 Jun, 14 | 67 | 67.50% | 26,551,608 | 27.64% | 109.42% | 1.42% | 53 | 32.50% | 10 | - |
| 31 Mar, 14 | 40 | - | 20,802,029 | - | 87.82% | - | 40 | - | - | - |
Heron Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Heron Therapeutics's stock was made by Collard Craig A on Jul 22 2024, selling 13,797 shares at - per share (valued at -).
Heron Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | 6 | 100.00% |
| Q1 2024 | 20 | 4 | 500.00% |
| Q4 2023 | 6 | 3 | 200.00% |
| Q3 2023 | 8 | 9 | 88.89% |
| Q2 2023 | 11 | 20 | 55.00% |
| Q1 2023 | 17 | 19 | 89.47% |
| Q4 2022 | 23 | 15 | 153.33% |
| Q3 2022 | 17 | 14 | 121.43% |
| Q2 2022 | 10 | 14 | 71.43% |
| Q1 2022 | 10 | 15 | 66.67% |
| Q4 2021 | 26 | 12 | 216.67% |
| Q3 2021 | 5 | 16 | 31.25% |
| Q2 2021 | 10 | 15 | 66.67% |
| Q1 2021 | 5 | 12 | 41.67% |
| Q4 2020 | 18 | 21 | 85.71% |
| Q2 2020 | 4 | 1 | 400.00% |
| Q4 2019 | 14 | 4 | 350.00% |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 4 | 1 | 400.00% |
| Q4 2018 | 11 | 4 | 275.00% |
6 total buy trades, and 6 total sell trades (buy/sell ratio of 1.00%) were made by Heron Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | 2 | - |
| Q2 2021 | - | 5 | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | - | 1 | - |
| Q2 2020 | - | 1 | - |
| Q4 2019 | 3 | 1 | 300.00% |
| Q3 2019 | - | - | - |
| Q2 2019 | 2 | 1 | 200.00% |
| Q4 2018 | - | 2 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Heron Therapeutics's stocks.
Heron Therapeutics Peer Ownership
HRTX Ownership FAQ
Who Owns Heron Therapeutics?
Heron Therapeutics is owned by institutional shareholders (11.36%), insiders (0.72%), and public (87.93%). The largest institutional shareholder of Heron Therapeutics is RUBRIC CAPITAL MANAGEMENT LP (17.67% of total shares) and the top mutual fund owner is HIGHLAND FUNDS II (1.58% of total shares).
Who are the major institutional shareholders of Heron Therapeutics?
Heron Therapeutics's major institutional shareholders are RUBRIC CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, BLACKROCK INC., ADAGE CAPITAL PARTNERS GP, L.L.C., and VELAN CAPITAL INVESTMENT MANAGEMENT LP. The top five shareholders own together 38.52% of the company's share outstanding.
How many Heron Therapeutics shareholders are there?
As of Jun 2024, there are 87 institutional shareholders of Heron Therapeutics.
What percentage of Heron Therapeutics is owned by RUBRIC CAPITAL MANAGEMENT LP?
RUBRIC CAPITAL MANAGEMENT LP owns 26.71M shares of Heron Therapeutics, representing 17.67% of the company's total shares outstanding, valued at $93.5M (as of Jun 2024).
What percentage of Heron Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 8.62M shares of Heron Therapeutics (HRTX), compromising 5.70% of the company, valued at $30.16M.
What percentage of Heron Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Heron Therapeutics. The company owns 8.33M of the company's shares outstanding (worth $29.14M).